The healthcare stock may not be running out of growth catalysts anytime soon.

Eli Lilly chairman and CEO David Ricks joins 'Squawk on the Street' to discuss the path to becoming a trillion dollar company, launch of its obesity pill, new innovation at the company, drug pipeline ...

Eli Lilly CEO Dave Ricks said upcoming Medicare coverage of obesity drugs could be a major catalyst for the launch of the company's closely watched experimental obesity pill, orforglipron. The launch ...

Right up front in its proxy filing with the Securites and Exchange Commission, Eli Lilly took care of justifying its $36.7 million compensation for CEO David Ricks in 2025. Since Ricks took over in ...

It's been a tough start for Eli Lilly (NYSE: LLY) stock this year. Entering this week, the pharmaceutical giant's value has fallen by 8%. While its five-year gains are still impressive at around 380%, ...